Dr. Pierre Kory (FLCCC Alliance) testifies to senate committee about I-MASK+ (incl. the following Q&A part)

This is an updated version of Dr. Kory’s testimony on December 8, 2020, including the Q & A part and in better quality (old version: youtube.com/video/CuHq12B_Tvk).

Appearing as a witness Tuesday morning before the Senate Committee on Homeland Security and Governmental Affairs—which held a hearing on "Early Outpatient Treatment: An Essential Part of a COVID-19 Solution"— Dr. Pierre Kory, President of the Frontline COVID-19 Critical Care Alliance (FLCCC), called for the government to swiftly review the already expansive and still rapidly emerging medical evidence on Ivermectin.

The data shows the ability of the drug Ivermectin to prevent COVID-19, to keep those with early symptoms from progressing to the hyper-inflammatory phase of the disease, and even to help critically ill patients recover.

Dr. Kory testified that Ivermectin is effectively a "miracle drug" against COVID-19 and called upon the government's medical authorities — the NIH, CDC, and FDA—to urgently review the latest data and then issue guidelines for physicians, nurse-practitioners, and physician assistants to prescribe Ivermectin for COVID-19.

Get all relevant information on the FLCCC Alliance's prophylaxis and treatment protocols for COVID-19 on www.flccc.net